Top

Journal of Neurology

Published in:

01-04-2012 | Letter to the Editors

Clinical heterogeneity and underlying pathophysiological mechanisms of lateral flexion of the trunk in Parkinson’s disease

Authors: Eduardo de Pablo-Fernández, Alberto Villarejo-Galende

Published in: Journal of Neurology | Issue 4/2012

Excerpt

Dear Sirs, …

Di Matteo A, Fasano A, Squintani G et al (2011) Lateral trunk flexion in Parkinson’s disease: EMG features disclose two different underlying pathophysiological mechanisms. J Neurol 258:740–745PubMedCrossRef

Cannas A, Solla P, Floris G et al (2005) Reversible Pisa syndrome in Parkinson’s disease during treatment with pergolide: a case report. Clin Neuropharmacol 28:252PubMedCrossRef

Gambarin M, Antonini A, Moretto G et al (2006) Pisa syndrome without neuroleptic exposure in a patient with Parkinson’s disease: case report. Mov Disord 21:270–273PubMedCrossRef

Cannas A, Solla P, Floris G et al (2009) Reversible Pisa syndrome in patients with Parkinson’s disease on dopaminergic therapy. J Neurol 256:390–395PubMedCrossRef

Kim JS, Park JW, Chung SW et al (2007) Pisa syndrome as a motor complication of Parkinson’s disease. Parkinsonism Relat Disord 13:126–128PubMedCrossRef

Solla P, Cannas A, Congia S et al (2008) Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson’s disease patient. J Neurol Sci 275:154–156PubMedCrossRef

Yokochi F (2006) Lateral flexion in Parkinson’s disease and Pisa syndrome. J Neurol 253(Suppl 7):S17–S20

Solla P, Cannas A, Tacconi P et al (2008) Lateral trunk flexion and Pisa syndrome in Parkinson’s disease. Are they really always different conditions although denoting similar features? J Neurol 255:450–451PubMedCrossRef

Ekbom K, Lindholm H, Ljungberg L (1972) New dystonic syndrome associated with butyrophenone therapy. Z Neurol 202:94–103PubMedCrossRef

10.

Suzuki T, Matsuzaka H (2002) Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management. CNS Drugs 16:165–174PubMedCrossRef

11.

Villarejo A, Camacho A, García-Ramos R et al (2003) Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol 26:119–121PubMedCrossRef

12.

Remington GJ (1988) The Pisa syndrome: possible role for serotonin and noradrenaline. J Clin Psychopharmacol 8:228–229PubMedCrossRef

13.

Melamed E, Djaldetti R (2006) Camptocormia in Parkinson’s disease. J Neurol 253(Suppl 7):S14–S16

Title: Clinical heterogeneity and underlying pathophysiological mechanisms of lateral flexion of the trunk in Parkinson’s disease
Authors: Eduardo de Pablo-Fernández
Alberto Villarejo-Galende
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 4/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6256-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clinical heterogeneity and underlying pathophysiological mechanisms of lateral flexion of the trunk in Parkinson’s disease

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2012

The role of advanced magnetic resonance imaging techniques in primary progressive MS

William Henry Battle (1855–1936)

Conjugate downward and upward vertical gaze palsy due to unilateral rostral midbrain infarction

Recurrent hypothermia with hyperhidrosis in two siblings: familial Shapiro syndrome variant

Ischemic stroke in young adults: classification and risk factors

Cerebral blood flow characteristics in patients with post-lumbar puncture headache